| Biomarker ID | 453 |
| PMID | 19505924 |
| Year | 2009 |
| Biomarker | Hemoglobin |
| Biomarker Basis | Expression Based |
| Biomolecule | Metabolites |
| Source | Blood |
| Subjects | Humans |
| Regulation | Increased expression in overall survival |
| Odds Ratio/Hazard Ratio/Relative Risk | Univariate: HR: 0.73 95% CI: (0.63-0.84) |
| Effect on Pathways | Pathways Include:- Alpha-hemoglobin stabilizing enzyme (AHSP) pathway,Nitric oxide effects,Oxygen/carbon dioxide exchange in erythrocytes,Folate metabolism,Selenium pathway |
| Experiment | Overall Survival Vs No Survival |
| Type of Biomarker | Prognostic |
| Cohort | 100 patients with prostate cancer were selected to determine the overall survival for checkup after 26 months. 49 were dead after the study and 51 were alive. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | Assays |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | HBA1 |